Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 07/18/2025 | CALL | $10.00 | 1,972 | +904 | +84.64% |
| 11/21/2025 | PUT | $7.50 | 758 | +456 | +150.99% |
| 08/15/2025 | CALL | $10.00 | 6,972 | +297 | +4.45% |
| 01/16/2026 | PUT | $10.00 | 367 | +271 | +282.29% |
| 11/21/2025 | PUT | $10.00 | 389 | +239 | +159.33% |
| 08/15/2025 | PUT | $10.00 | 152 | +79 | +108.22% |
| 01/15/2027 | PUT | $7.50 | 2,532 | 0 | |
| 01/15/2027 | PUT | $12.50 | 64 | 0 | |
| 01/15/2027 | PUT | $15.00 | 20 | 0 | |
| 01/15/2027 | PUT | $17.50 | 0 | 0 | |
| 08/15/2025 | PUT | $5.00 | 18 | -1 | -5.26% |
| 01/16/2026 | CALL | $5.00 | 777 | -2 | -0.26% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Fidelity Growth Company Fund | 3.14% | 1.87M | 89.43M |
| Vanguard Total Stock Market Index Fund | 2.60% | 1.55M | 74.07M |
| Vanguard Specialized-Health Care Fund | 2.36% | 1.41M | 67.13M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.33% | 1.39M | 66.39M |
| Vanguard Small-Cap Index Fund | 2.18% | 1.3M | 62.18M |
| iShares Russell 2000 ETF | 1.91% | 1.14M | 54.53M |
| Fidelity Select Portfolios - Biotechnology | 1.66% | 989.75k | 47.24M |
| Hartford Mid Cap Fund | 1.38% | 821.38k | 39.2M |
| Vanguard Small-Cap Growth Index Fund | 1.26% | 753.84k | 35.98M |
| Fidelity Series Growth Company Fund | 1.20% | 715.81k | 34.17M |
Comprehensive Market Analysis of Latest Published Different Types of Depression Reports | DelveInsight
02/25 02:00 pm
GlobeNewswire Inc.
Read moreDeal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok
01/31 03:20 pm
Benzinga
Read moreKuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm
01/24 02:38 pm
GlobeNewswire Inc.
Read moreBiogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analysts
01/13 03:06 pm
Benzinga
Read moreSage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE
10/28 10:10 am
Benzinga
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
10/24 08:02 pm
Benzinga
Read moreSage Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. October 28, 2024 Deadline to file Lead Plaintiff Motion
10/23 08:06 pm
GlobeNewswire Inc.
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
10/22 11:05 pm
Benzinga
Read moreSAGE DEADLINE NOTICE: Rosen, A HIGHLY RECOGNIZED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action – SAGE
10/22 07:35 pm
GlobeNewswire Inc.
Read moreSage Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. October 28, 2024 Deadline to file Lead Plaintiff Motion
10/21 04:43 pm
GlobeNewswire Inc.
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
10/21 05:49 am
Benzinga
Read moreSAGE DEADLINE: RLF, A TOP-RANKED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action – SAGE
10/19 09:45 pm
GlobeNewswire Inc.
Read moreROSEN, A TOP-RANKED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action – SAGE
10/17 08:42 pm
GlobeNewswire Inc.
Read moreROSEN, A LEADING LAW FIRM, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
10/11 09:07 pm
GlobeNewswire Inc.
Read moreGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)
10/09 12:00 pm
GlobeNewswire Inc.
Read moreROSEN, LEADING INVESTOR COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
10/03 06:44 pm
GlobeNewswire Inc.
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
09/30 08:45 am
Benzinga
Read moreROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
09/29 09:08 pm
GlobeNewswire Inc.
Read moreGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)
09/27 02:33 pm
GlobeNewswire Inc.
Read moreROSEN, LEADING TRIAL ATTORNEYS, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
09/26 07:26 pm
GlobeNewswire Inc.
Read moreBiogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate
09/26 10:38 am
Benzinga
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
09/25 08:30 am
Benzinga
Read moreGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)
09/20 12:49 pm
GlobeNewswire Inc.
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
09/18 08:15 am
Benzinga
Read moreDeadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)
09/17 06:37 pm
Benzinga
Read moreSAGE THERAPEUTICS, INC. (NASDAQ: SAGE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Sage Therapeutics, Inc. Investors of Upcoming Deadline
09/16 02:59 pm
GlobeNewswire Inc.
Read moreROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
09/14 09:36 am
GlobeNewswire Inc.
Read moreGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc. (SAGE) Investors
09/13 03:14 pm
Benzinga
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
09/13 08:30 am
Benzinga
Read moreINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc. (SAGE) Investors
09/12 01:15 pm
Benzinga
Read moreThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc. (SAGE) Investors
09/12 12:07 pm
Benzinga
Read moreINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Sage Therapeutics, Inc. (SAGE) on Behalf of Investors
09/11 07:55 pm
Benzinga
Read moreROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
09/10 02:53 pm
GlobeNewswire Inc.
Read moreThe Law Offices of Frank R. Cruz Announces Investigation of Sage Therapeutics, Inc. (SAGE) on Behalf of Investors
09/10 12:04 pm
Benzinga
Read moreSAGE THERAPEUTICS, INC. (NASDAQ: SAGE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Sage Therapeutics, Inc. Investors of Upcoming Deadline
09/09 04:59 pm
GlobeNewswire Inc.
Read moreSAGE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
09/07 10:07 am
GlobeNewswire Inc.
Read moreONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics
09/06 09:55 am
GlobeNewswire Inc.
Read moreSAGE INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
09/01 10:11 am
GlobeNewswire Inc.
Read moreROSEN, NATIONAL TRIAL COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
09/01 08:32 am
GlobeNewswire Inc.
Read moreSAGE THERAPEUTICS, INC. (NASDAQ: SAGE) INVESTOR ALERT: Investors With Large Losses in Sage Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
08/30 01:45 am
GlobeNewswire Inc.
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
08/29 06:13 pm
Benzinga
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
08/29 03:01 pm
Benzinga
Read moreSAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Sage Therapeutics Class Action Lawsuit
08/29 02:33 pm
GlobeNewswire Inc.
Read moreGlobal Maternal Mental Health Market to Exhibit Growth at Tremendous CAGR of ~15% by 2030 | DelveInsight
08/14 01:00 pm
GlobeNewswire Inc.
Read moreBiogen (BIIB) Q2 Earnings & Sales Beat, 2024 Guidance Raised
08/01 12:25 pm
Zacks Investment Research
Read more